The purpose of this study was to compare the efficacy and safety of GLP-1 RAs, DPP-4i, and SGLT-2i in combination with basic insulin and oral hypoglycemic agents in poorly treated T2DM through umbrella review, respectively. The gene discussed is INS; the disease is type 2 diabetes mellitus.